Twist Bioscience Corporation TWST Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$44.02M-11.9% | -$30.51M+3.4% | -$27.14M+21.7% | $20.39M+124% | -$39.33M+13.5% | ||
| $6.41M+0.2% | $6.19M-2.9% | $6M-9.8% | $6.07M-26.9% | $6.4M-22.9% | ||
| $18.94M-6.8% | $13.27M+10.7% | $16.08M+30.3% | $16.06M+16.9% | $20.33M+47.0% | ||
| $14.24M+32.8% | -$6.83M-250% | $7.21M— | $0+100% | $10.72M— | ||
| $590K+122% | $4.62M+924% | $2.37M+154% | $5.08M+369% | -$2.66M-447% | ||
| $69K-90.3% | $1.47M-74.2% | $0+100% | $3.19M+366% | $711K+147% | ||
| -$5.78M-4,256% | $1.51M-51.9% | $2.32M+719% | $158K-42.1% | $139K-85.5% | ||
| $641K+141% | -$225K-163% | $965K— | $0+100% | $266K+3,056% | ||
| $498K+160% | $336K+1,580% | -$240K+54.9% | -$1.15M— | -$831K-71.7% | ||
| —— | —— | $0— | $0— | $0— | ||
| -$17.56M-35.2% | -$24.81M-15.8% | -$11.81M+22.9% | -$1.4M+78.0% | -$12.99M+33.1% | ||
| $7.89M+90.3% | $9.97M+340% | $12.43M+521% | $9.17M+850% | $4.14M+587% | ||
| $4.72M-4.3% | $20.51M-0.4% | $21.14M-0.3% | $2.73M+56.5% | $4.93M-53.6% | ||
| $5M-34.6% | $20.55M-3.6% | $21.16M-3.4% | $0-100% | $7.65M+27.5% | ||
| -$12.71M-791% | -$9.93M-547% | -$12.4M-865% | -$9.4M-1,222% | -$1.43M+72.8% | ||
| $0— | $0-100% | —— | —— | —— | ||
| $1.79M+132% | $300K-89.8% | $3.79M+97.8% | $1.83M-37.3% | $772K-41.4% | ||
| $4.14M+29.5% | $298K-98.3% | $5.57M+53.7% | $1.83M-37.2% | $3.2M+74.8% | ||
| —— | $9K+117% | $163K+123% | -$71K-3,650% | $104K— | ||
| -$26.13M-135% | -$34.44M-579% | -$18.48M-43.2% | -$9.04M-116% | -$11.11M+51.5% | ||
| $474K+3,546% | $184K+6,033% | $660K— | $7K-70.8% | $13K-95.7% | ||
| —— | —— | $0— | $0— | $0— | ||
| —— | -$12.44M-4.9% | —— | —— | —— | ||
| $11.13M+1,082% | $7.74M+3,006% | $1.9M+434% | $2.71M— | -$1.13M— | ||
| $498K+160% | $336K+1,580% | -$240K+54.9% | -$1.15M— | -$831K-71.7% | ||
| $5M-34.6% | $20.55M-3.6% | $21.16M-3.4% | $0-100% | $7.65M+27.5% | ||
| $8K+60.0% | $2K-66.7% | $2K-75.0% | $3K-57.1% | $5K-99.7% | ||
| —— | —— | $1.78M+3.8% | —— | —— | ||
| $1.79M+132% | $300K-89.8% | $3.79M+97.8% | $1.83M-37.3% | $772K-41.4% | ||
| $4.36M— | $1.18M-44.7% | $586K— | $493K+179% | —— | ||
| $0— | $0-100% | —— | —— | —— | ||
| —— | $24.77M— | —— | —— | $0— | ||
| —— | —— | $0— | $0— | $0— | ||
| $474K+3,546% | $184K+6,033% | $660K— | $7K-70.8% | $13K-95.7% | ||
| -$25.45M-48.5% | -$34.79M-46.8% | -$24.24M-39.9% | -$10.57M-43.9% | -$17.13M+14.5% | ||
| -$25.45M-48.5% | -$34.79M-46.8% | -$24.24M-39.9% | -$10.57M-43.9% | -$17.13M+14.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Twist Bioscience Corporation generate?
- Twist Bioscience Corporation (TWST) generated -$55.6M in operating cash flow over the trailing twelve months.
- What is Twist Bioscience Corporation's free cash flow?
- After $39.5M of capital expenditures, Twist Bioscience Corporation's free cash flow was -$95.0M over the trailing twelve months, down 45.1% year over year.
- Where does Twist Bioscience Corporation's cash flow data come from?
- Every line is extracted from Twist Bioscience Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
